Denovo Sciences, Sidra Medicine, and Weill Cornell Medicine-Qatar Announce Collaboration to Discover Drug Candidates for Homocystinuria

Posted On By
0 0
Read Time:28 Second

Doha – October 22, 2025 – Denovo Sciences Inc., a pioneer in AI-driven drug discovery based on synthetic data, Weill Cornell Medicine-Qatar (WCM-Q), a leading biomedical research and educational institution, and Sidra Medicine, a women’s and children’s healthcare organization, are engaging in a collaboration to identify and develop novel drug candidates for homocystinuria, a rare and genetic metabolic disorder. The partnership aims to address a significant unmet medical need, particularly in the MENA region, where the condition has one of the highest prevalence rates in the world.

Homocystinuria is an inherited disorder that impair

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *